Page last updated: 2024-08-22

camptothecin and er-086526

camptothecin has been researched along with er-086526 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dean-Colomb, W; Esteva, FJ	1
Bousoik, E; Elghazaly, H; Elmazar, MMA; Tolaney, SM; Tolba, MF	1

Reviews

2 review(s) available for camptothecin and er-086526

Article	Year
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer. Seminars in oncology, 2008, Volume: 35, Issue:2 Suppl 2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine	2008
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:10 Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal; Antineoplastic Agents; Camptothecin; Cyclin-Dependent Kinase Inhibitor Proteins; Drug Therapy, Combination; Female; Furans; High-Intensity Focused Ultrasound Ablation; Humans; Immune Checkpoint Inhibitors; Immunoconjugates; Immunotherapy; Ketones; Phosphoinositide-3 Kinase Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Purinergic P1 Receptor Antagonists; Receptor, ErbB-2; Trastuzumab; Triple Negative Breast Neoplasms	2021

Article

Year

Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

Seminars in oncology, 2008, Volume: 35, Issue:2 Suppl 2

Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine

2008

Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:10

Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal; Antineoplastic Agents; Camptothecin; Cyclin-Dependent Kinase Inhibitor Proteins; Drug Therapy, Combination; Female; Furans; High-Intensity Focused Ultrasound Ablation; Humans; Immune Checkpoint Inhibitors; Immunoconjugates; Immunotherapy; Ketones; Phosphoinositide-3 Kinase Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Purinergic P1 Receptor Antagonists; Receptor, ErbB-2; Trastuzumab; Triple Negative Breast Neoplasms

2021